Line 75: | Line 75: | ||
− | <tr | + | <tr><td colspan=4 align=center valign=center> |
<h3><a class="myLink" href="/Team:TUDelft">iGEM TU Delft</a></h3> | <h3><a class="myLink" href="/Team:TUDelft">iGEM TU Delft</a></h3> | ||
<p> | <p> | ||
− | Their iGEM project is called CASE13A. Both our projects are similar in terms of the use of Cas13a and paper microfluidics. Our collaboration started with our meeting in Delft. We were excited to see that TU Delft were also working with Cas13a as their major protein. We both are trying to work on different ways of tackling the problem of the antibiotic resistance using Cas13a. Therefore we decided to collaborate since it gave us the opportunity to discuss the challenges and also to try out new stuffs together. We started a collaboration for our <a class="myLink" href="/Team:Munich/Software">software</a> since we both were working on optimizing the crRNA for the different targets. In our team, we designed a software that could give us the best design and structure of the crRNA for different targets. For this we created a database of different possible sequences using NUPACK and other platforms. | + | Their iGEM project is called CASE13A. Both our projects are similar in terms of the use of Cas13a and paper microfluidics. Our collaboration started with our meeting in Delft. We were excited to see that TU Delft were also working with Cas13a as their major protein. We both are trying to work on different ways of tackling the problem of the antibiotic resistance using Cas13a. Therefore we decided to collaborate since it gave us the opportunity to discuss the challenges and also to try out new stuffs together. We started a collaboration for our <a class="myLink" href="/Team:Munich/Software">software</a> since we both were working on optimizing the crRNA for the different targets. In our team, we designed a software that could give us the best design and structure of the crRNA for different targets. For this we created a database of different possible sequences using NUPACK and other platforms. Team Delft had a similar project where they predict the part of the target that can best serve as a crRNA. We provided them with a list of possible targets and best crRNAs structures for their software. </p> |
</td> | </td> | ||
<td colspan=2 align=center valign=center> | <td colspan=2 align=center valign=center> | ||
− | <a href="/Team:TUDelft"><img src="https:// | + | <a href="/Team:TUDelft"><img src="https://static.igem.org/mediawiki/2017/e/e7/T--Munich--Collaborations_TUDelft_Logo.png"></a> |
+ | </td> | ||
+ | </tr> | ||
+ | |||
+ | <tr class="lastRow"><td colspan=6 align=center valign=center> | ||
+ | <div class="captionPicture"> | ||
+ | <img width=600 src="https://static.igem.org/mediawiki/2017/0/05/T--Munich--Collaborations_TUDelft_Skype.jpg" alt="Skype session with team Delft"> | ||
+ | <p>One of the skype sessions with TU Delft</p> | ||
+ | </div> | ||
+ | <p> | ||
+ | Also, team Delft sent us the Tardigrade intrinsically Disordered Proteins(TDPs) to experiment them with our Cas13a and to check the activity and stability of the Cas13a when used together with TDPs. From our team, Dawa did the characterization of the TDPs that were sent by the team TU Delft. Both our teams are using Cas13a but from different strains. Our team mostly used Leptrotricia buccalis and Leptrotricia wadei Cas13a for our experiments. We did also tried the Leptrotricia shahi but we couldn't purify it that well for our experiments. Team TU Delft were using the Leptroticia shahi Cas13a for their experiments. | ||
+ | </p> | ||
+ | <p> | ||
+ | During the characterization of the TDPs, Team TU Delft found that whenever their Cas13a was dried in combination with a TDP of the type CAHS, the resuspended Cas13a would start cleaving RNA even in absence of the target RNA, hence losing its specificity. We therefore did the characterization of the TDPs they provided with our Cas13a (Lbu) and repeated the exact same drying experiment with the CAHS protein, in order to corroborate our results and to find the cause of such an unexpected result. As observed in figure 1 below, we also got the same unexpected results when Cas13a was tried with CAHS TDP. | ||
+ | </p> | ||
+ | </td> | ||
+ | </tr> | ||
+ | |||
+ | <tr> | ||
+ | <td colspan=2 align=center valing=center> | ||
+ | <div class="captionPicture"> | ||
+ | <img width=300 src="https://static.igem.org/mediawiki/2017/4/4f/T--Munich--Collaborations_TuDelft_Package.jpg" alt="Skype session with team Delft"> | ||
+ | <p>TDP package from TU Delft</p> | ||
+ | </div> | ||
+ | </td> | ||
+ | <td colspan=4 align=center valing=center> | ||
+ | <div class="captionPicture"> | ||
+ | <img width=600 src="https://static.igem.org/mediawiki/2017/f/f1/T--Munich--Collaborations_TUDelft_Results.png" alt="Skype session with team Delft"> | ||
+ | <p>Figure 1: RNAseAlert fluorescence assay with our Cas13a (Lbu) and TDP from TU Delft</p> | ||
+ | </div> | ||
</td> | </td> | ||
</tr> | </tr> | ||
Line 87: | Line 116: | ||
<tr class="lastRow"> | <tr class="lastRow"> | ||
<td colspan=2 align=center valign=center> | <td colspan=2 align=center valign=center> | ||
− | <a href="/Team:BOKU-Vienna"><img src="https:// | + | <a href="/Team:BOKU-Vienna"><img src="https://static.igem.org/mediawiki/2017/1/11/T--Munich--Collaborations_Vienna_Logo.png" alt="Diagram for Cas13a's function" width=360></a> |
</td> | </td> | ||
<td colspan=4 align=center valign=center> | <td colspan=4 align=center valign=center> | ||
Line 102: | Line 131: | ||
</td> | </td> | ||
<td colspan=2 align=center valign=center> | <td colspan=2 align=center valign=center> | ||
− | <a href="/Team:Bristol"><img src="https://static.igem.org/mediawiki/2017/5/5d/T--Bristol--TeamLogo.svg" width= | + | <a href="/Team:Bristol"><img src="https://static.igem.org/mediawiki/2017/5/5d/T--Bristol--TeamLogo.svg" width=400 alt="Diagram for Cas13a's function"></a> |
+ | </td> | ||
+ | </tr> | ||
+ | |||
+ | <tr class="lastRow"> | ||
+ | <td colspan=2 align=center valign=center> | ||
+ | <a href="/Team:Berlin_diagnostX"><img src="https://static.igem.org/mediawiki/2017/c/cf/T--Munich--Collaborations_Berlin_Logo.png" alt="Berlin Diagnost-X logo" width=360></a> | ||
+ | </td> | ||
+ | <td colspan=4 align=center valign=center> | ||
+ | <h3><a class="myLink" href="/Team:Berlin_diagnostX">iGEM Berlin diagnostX</a></h3> | ||
+ | <p> | ||
+ | Their iGEM project is called Wormspotter, where they want to use toehold switch to diagnose tape worm infections. Tape worm infections are very common in many countries in Asia and Africa, and the team Berlin wants to help make the detection of such infections rapid and affordable. We have some similarities in the project regarding the use of RNA and paper strips. They are also working a lot on RNA extraction and on amplification of the RNA product. They also want to have a visible readout on the paper to detect the presence of tapeworm RNA as we do. Therefore we decided to help each other by addressing each otherÕs problems and by helping to solve them. We helped each other by discussing our problems and providing tips to solve them. We did Skype meeting sessions and exchanged emails to keep each other updated. We also talked on how the challenges of RNA amplification could be optimized and how we can make good use of each otherÕs detection system.</p> | ||
</td> | </td> | ||
</tr> | </tr> |
Revision as of 12:58, 29 October 2017
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|